Skip to main content
Equibles

Squarepoint Ops LLC

Position in ABT — Abbott Laboratories

CIK 1642575 NEW YORK, NY
Back to ABT Full portfolio

Position in ABT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$40,818,717
+$35,012,779 QoQ
Shares Held
397,572
+757.9% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in ABT Over Time

Shares Held

Position Value (USD)

Derivatives in ABT

reported options exposure · as of Mar 31, 2026
CallValue
$11,950,788
CallShares
116,400
PutValue
$7,648,915
PutShares
74,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

Squarepoint Ops LLC holds $569,835,394 across 47 Medical Devices names. ABT ranks #6 (7.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MDT
Medtronic plc
 1,683,504 $145,875,621
2 BSX
Boston Scientific Corp
 1,589,914 $99,767,103
3 DXCM
Dexcom Inc
 1,154,441 $72,498,894
4 MASI
Masimo Corp
 389,359 $69,255,285
5 PEN
Penumbra Inc
 147,806 $48,535,056
6 ABT
Abbott Laboratories
This page 		397,572 $40,818,717
7 SYK
Stryker Corp
 109,964 $36,133,070
8 GKOS
GLAUKOS Corp
 108,049 $11,632,555

All Filings in ABT

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $11,950,788 116,400
2026-03-31 $7,648,915 74,500
2026-03-31 $40,818,717 397,572
2025-12-31 $1,603,712 12,800
2025-12-31 $5,805,938 46,340
2025-12-31 $24,782,362 197,800
2025-09-30 $6,218,030 46,424
2025-09-30 $15,081,644 112,600
2025-09-30 $1,392,976 10,400
2025-06-30 $54,089,952 397,691
2025-06-30 $72,860,557 535,700
2025-06-30 $8,935,857 65,700
2025-03-31 $35,324,695 266,300
2025-03-31 $6,193,030 46,687
2025-03-31 $42,673,505 321,700
2024-12-31 $14,625,123 129,300
2024-12-31 $12,577,832 111,200
2024-12-31 $5,271,152 46,602
2024-09-30 $115,292,954 1,011,253
2024-09-30 $6,475,768 56,800
2024-09-30 $786,669 6,900
2024-06-30 $1,475,522 14,200
2024-06-30 $130,302,932 1,253,998
2024-06-30 $3,927,798 37,800
2024-03-31 $55,880,143 491,643
2024-03-31 $3,000,624 26,400
2024-03-31 $25,448,474 223,900
2023-12-31 $17,641,909 160,279
2023-12-31 $11,029,014 100,200
2023-12-31 $4,116,618 37,400
2023-09-30 $14,582,413 150,567
2023-06-30 $32,983,782 302,548
2023-03-31 $28,843,202 284,843
2023-03-31 $5,964,214 58,900
2023-03-31 $5,873,080 58,000
2022-12-31 $8,984,115 81,830
2022-12-31 $1,053,984 9,600
2022-12-31 $1,075,942 9,800
2022-09-30 $1,083,712 11,200
2022-09-30 $8,195,281 84,697
2022-09-30 $1,103,064 11,400
2022-06-30 $28,994,990 266,866
2022-06-30 $369,410 3,400
2022-06-30 $347,680 3,200
2022-03-31 $1,420,320 12,000
2022-03-31 $33,947,541 286,816
2022-03-31 $1,420,320 12,000
2021-12-31 $7,068,947 50,227
2021-12-31 $4,391,088 31,200
2021-09-30 $26,902,335 227,735

Report a Problem

Category
Description
Email (optional, for follow-up)